Publications

Mayeta Clark 2015

Evaluating a Potential Dose-Sparing Self-Amplifying RNA Vaccine for Induction of Functional Antibodies to Blood-Stage Plasmodium falciparum Malaria

October 31, 2026

Introduction: Next-generation malaria vaccines are urgently needed to provide greater efficacy and longevity. Antibodies targeting blood-stage merozoites can confer protection…

Read More

Community patient follow-up as a part of P. vivax case management in Cambodia: a mixed methods study

September 29, 2026

Background Community health workers are key to improving global health. In Cambodia, a malaria-endemic country, village malaria workers (VMWs) have…

Read More

Anopheles salivary antibody biomarker outcomes to assess the effectiveness of topical repellent in Southeast Myanmar

September 21, 2026

Background Measurement of human antibodies against Anopheles salivary proteins that are injected during mosquito bites may serve as biomarkers of…

Read More

A systematic review and individual patient data meta-analysis to determine the effect of primaquine dose on efficacy, tolerability and safety in uncomplicated Plasmodium vivax malaria in Latin America

September 21, 2026

Background Primaquine is widely used to prevent relapses of Plasmodium vivax malaria, but the optimal dose in Latin America is…

Read More

Diagnostic accuracy of a malaria rapid diagnostic test compared with polymerase chain reaction in Lao People’s Democratic Republic: a secondary data analysis

September 17, 2026

Background Malaria rapid diagnostic tests (RDTs) are widely used in malaria endemic countries in both clinical and community settings for…

Read More

Targeting a malaria merozoite surface protein with mRNA vaccine generates multifunctional antibodies

September 16, 2026

Introduction: Malaria is a leading health problem with high disease burden and mortality rates worldwide. Currently approved vaccines target the…

Read More

Splenic Tropism and Spleen-Modulated Systemic Inflammation in Acute Plasmodium vivax Malaria

September 10, 2026

In chronic Plasmodium vivax (Pv) infection, the spleen accounts for over 98% of total-body parasite biomass. Whether splenic tropism also…

Read More

Protocol for IgG Antibody Measurements against Plasmodium vivax serological exposure markers using a Luminex assay

September 9, 2026

Quantifying antibodies against Plasmodium vivax enables the detection of both recent and past P. vivax exposure and may help identify individuals with clinically silent…

Read More

Community perceptions, trust, and experiences of malaria clinical research and participation in rural Cambodia

September 8, 2026

Introduction Understanding community perspectives on malaria treatment and research participation is important for designing ethically appropriate community engagement strategies, strengthening…

Read More

Protective immunity to clinical malaria is modified by the genetic diversity of P. falciparum antigens

September 5, 2026

Prioritising malaria vaccine targets requires understanding immunity to genetically and structurally diverse parasite antigens, influencing antibody measurements and durability. We…

Read More

1 2 3 … 37

-->